7:47 am Oragenics advances towards identification of lead antibiotic clinical candidate; lantibiotic pipeline through exclusive channel collaboration with XON generates several new MU1140 analogs with activity against certain drug-resistant
View todays social media effects on OGEN
View the latest stocks trending across Twitter. Click to view dashboard
See who Oragenics is hiring next, click here to view
